UK markets open in 5 hours 30 minutes

IDEXX Laboratories, Inc. (IDXX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
693.74+10.71 (+1.57%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 559.16B
Enterprise value 359.81B
Trailing P/E 89.27
Forward P/E 176.24
PEG ratio (5-yr expected) 14.71
Price/sales (ttm)20.70
Price/book (mrq)84.27
Enterprise value/revenue 320.93
Enterprise value/EBITDA 766.78

Trading information

Stock price history

Beta (5Y monthly) 0.90
52-week change 389.20%
S&P500 52-week change 336.19%
52-week high 3696.35
52-week low 3347.54
50-day moving average 3630.55
200-day moving average 3543.42

Share statistics

Avg vol (3-month) 3356.38k
Avg vol (10-day) 3379.97k
Shares outstanding 585.28M
Implied shares outstanding 6N/A
Float 84.43M
% held by insiders 10.95%
% held by institutions 187.65%
Shares short (29 Jun 2021) 4835.25k
Short ratio (29 Jun 2021) 42.46
Short % of float (29 Jun 2021) 41.11%
Short % of shares outstanding (29 Jun 2021) 40.98%
Shares short (prior month 27 May 2021) 4860.02k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 315 Jun 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Mar 2021


Profit margin 23.59%
Operating margin (ttm)27.92%

Management effectiveness

Return on assets (ttm)23.67%
Return on equity (ttm)166.25%

Income statement

Revenue (ttm)2.86B
Revenue per share (ttm)33.48
Quarterly revenue growth (yoy)24.20%
Gross profit (ttm)1.57B
EBITDA 895.67M
Net income avi to common (ttm)674.21M
Diluted EPS (ttm)7.77
Quarterly earnings growth (yoy)82.70%

Balance sheet

Total cash (mrq)351.16M
Total cash per share (mrq)4.12
Total debt (mrq)999.84M
Total debt/equity (mrq)142.14
Current ratio (mrq)1.77
Book value per share (mrq)8.23

Cash flow statement

Operating cash flow (ttm)744.61M
Levered free cash flow (ttm)557.21M